Poland· PL-100060789

Sermion

A nicergoline product containing nicergolinum, registered in Poland by Viatris Healthcare Limited. The same ATC class is registered in 2 of our 19 countries.

ATC C04AE02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSermionATCC04AE02REGISTER NO.PL-100060789PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Nicergoline is registered in 2 of 19 countries.

Countries holding a registration under ATC C04AE02 (nicergoline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 1 of them publish a price we can compare per daily dose

Nicergoline · ATC C04AE02

2 / 19 countries

  • Germany
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Nicergolinum
Manufacturer
Viatris Healthcare Limited
Country
Poland (PL)
ATC code
C04AE02
ATC class
Nicergoline
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990155712
  • gtin
    05909990155729
  • gtin
    05909990155736

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nicergoline in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nicergoline products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Austria · Ergotop, Sermion
  • Bulgaria · Нерголин, Сермион
  • Germany · Nicergolin Neuraxpharm
  • Spain · Varson
  • Hungary · Ergotop, Sermion
  • Latvia · Sermion
  • Portugal · Sermion
  • Romania · Nicergolină Lph Labormed, Nicergolina Slavia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1d2c1182-0655-4328-80ea-f9f29dfa0288
GET /v1/drugs/1d2c1182-0655-4328-80ea-f9f29dfa0288?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki drażowane",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909990155712 ¦ Rp ¦ Skasowane ¦ 9065\n50 draż. \n05909990155729 ¦ Rp ¦ 15476\n25 tabl. w blistrze\n05909990155736 ¦ Rp ¦ 17469\n50 tabl. w blistrach",
  "substance": "Nicergolinum 10 mg",
  "common_name": "Nicergolinum",
  "pl_product_id": "100060789",
  "pozwolenie_nr": "01557",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about nicergoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.